Breaking
Friday, June 19, 2026

FDA News News

🇪🇺 EMA

EMA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 36 articles

High impact NewsJun 14, 2026

FDA approves capivasertib plus abiraterone and prednisone in PTEN-deficient mHSPC

FDA · prostate cancer · 6 min

Dr. Elena Rossi
High impact NewsJun 13, 2026

Truqap gains US approval in PTEN-deficient metastatic prostate cancer

FDA · prostate cancer · 6 min

Dr. Elena Rossi
High impact NewsJun 8, 2026

Eye drugs list: Sodium hyaluronate, tafluprost, tobramycin uses

FDA · dry eyes · 5 min

Dr. Elena Rossi
High impact NewsJun 6, 2026

Regulatory round-up: 2 February 2026 – EMA opinions, FDA approvals, and what they mean for pharma

FDA · 4 min

Dr. Elena Rossi
High impact NewsJun 5, 2026

India-Oman CEPA Fast-Tracks Drug Approvals, Cuts Export Barriers for Pharma

4 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

EU Commission Advances Critical Medicines Act: Market Implications

FDA · 7 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

WHO/Europe Initiative on Access to Novel Medicines: Market Implications for Pharma

FDA · 6 min

Dr. Elena Rossi
Critical impact NewsJun 4, 2026

Insights from ESMO Asia: Nadia Harbeck on Oncology Advances

FDA · oncology · 4 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

Owkin and AstraZeneca Enhance AI Collaboration for Drug Research

FDA · 4 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data

FDA · cancer · 4 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights

FDA · breast cancer · 5 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

CHMP May 2026 Output: A New Era in Drug Approvals

FDA · 5 min

Dr. Elena Rossi